Tata Chemicals Q1 FY27 Share Price & Earnings Call Analysis

Financials of Tata Chemicals

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Tata Chemicals

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +4,4074,2183,9983,7303,4753,7893,9993,5903,5093,7193,8773,5503,438
Expenses +3,4423,1753,1913,1883,0323,2153,3813,1563,1823,0703,3403,2053,164
Operating Profit9651,043807542443574618434327649537345274
OPM %22%25%20%15%13%15%15%12%9%17%14%10%8%
Other Income +866718798-861116152-102913812821-1,760
Interest133123145132130133145148137147144146153
Depreciation234229234246271273277280293280285293343
Profit before tax684758615262-819284348-4-74360236-73-1,982
Tax %-1%23%20%26%3%33%23%425%-34%12%35%-5%7%
Net Profit +692587495194-841190267-21-49316154-69-2,116
EPS in Rs27.8320.8816.806.20-33.365.897.61-2.08-2.209.893.02-3.65-83.67

Financials of Tata Chemicals

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +17,20414,87310,34610,27010,33710,35710,20012,62216,78915,42114,88714,584
Expenses +15,30512,7778,2496,9268,5388,4118,69310,31712,96912,57412,93412,779
Operating Profit1,9002,0962,0973,3441,7991,9451,5062,3053,8202,8471,9531,805
OPM %11%14%20%33%17%19%15%18%23%18%13%12%
Other Income +1832102932627856,480254486218-521287-1,473
Interest461525297326354342367303406530563590
Depreciation4635265125185686667598068929801,1231,201
Profit before tax1,1591,2551,5802,7631,6617,4166341,6822,740816554-1,459
Tax %30%20%22%2%17%3%31%16%11%47%30%18%
Net Profit +8021,0061,2342,7021,3877,2284361,4052,434435387-1,715
EPS in Rs23.4130.2438.9895.4945.37274.9710.0649.3790.9310.529.22-74.41
Dividend Payout %53%33%28%23%28%4%99%25%19%143%119%-13%

Financials of Tata Chemicals

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital255255255255255255255255255255255255
Reserves5,2976,6007,65310,84712,08612,64314,03517,99819,46621,98621,33920,951
Borrowings +8,3799,0907,0726,1086,1307,7026,9337,0246,2965,5637,0728,001
Other Liabilities +6,8728,4028,6078,6488,3987,0737,1158,5668,9238,9079,0849,824
Total Liabilities20,80224,34623,58725,85826,86927,67328,33733,84334,94036,71137,75039,031
Fixed Assets +11,35913,43112,64412,78713,55115,35615,26116,04417,09217,86119,60020,626
CWIP1893503334097748351,0941,6682,4102,2171,9131,014
Investments4432,1882,7872,8405,6154,2855,8167,6837,4489,7399,1449,886
Other Assets +8,8118,3777,8229,8226,9297,1986,1678,4487,9906,8947,0937,505
Total Assets20,80224,34623,58725,85826,86927,67328,33733,84334,94036,71137,75039,031

Financials of Tata Chemicals

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +1,2742,3323,5311,8701,5811,7802,0371,6452,9713,0161,7611,269
Cash from Investing Activity +-663-463-9852,714-1,927-2,285-1,147-817-1,149-605-1,667-809
Cash from Financing Activity +-1,087-1,802-2,341-2,089-1,712-129-1,456-755-2,076-2,49429-670
Net Cash Flow-477682052,494-2,058-634-56573-254-83123-210
Free Cash Flow7091,6452,8881,1405026118043801,4271,193-191129
CFO/OP86%129%190%71%115%99%142%83%88%120%102%67%

Financials of Tata Chemicals

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days738874465156505657454752
Inventory Days137119244304315347257318282341324353
Days Payable13899232307269302256338289320318293
Cash Conversion Cycle721078643971005135506653113
Working Capital Days-431-427-2-102-28-2929-22-211
ROCE %11%11%10%16%9%36%4%8%12%8%4%4%

Continue your research

What Tata Chemicals's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Sudarshan Chemical Industries Ltd (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Ch. (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

  • Deepak Fertilis. (Q1 FY27)

    Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF